COLL
Collegium Pharmaceutical, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$35.54-1.50%
Price as of Jul 20, 2026
COLL valuation
Collegium Pharmaceutical, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 4.28x
- P/E 2026E
- 4.04x
- P/E 2027E
- 4.54x
- P/E 2028E
- 4.35x
- P/S forward
- 1.14x
Trailing multiples
- P/E TTM
- 15.00x
- PEG TTM
- 0.06x
- Price / book
- 3.69x
- Price / sales
- 1.45x
- Price / cash flow
- 3.48x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 1.93x
- EV / EBITDA
- 2.52x
- EV / EBIT
- 8.10x
- Market cap
- $1.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.